INTRODUCTION
Protein modification by glycosylphosphatidylinositol (GPI) anchors is a highly conserved posttranslational modification in eukaryotes (Ferguson et al., 2008) . Approximately 150 proteins are modified by GPI, which is vital for embryonic development, immune responses, and neurogenesis in mammals. GPI biosynthesis and attachment to proteins are carried out on the endoplasmic reticulum (ER) membrane. Many genes involved in the GPI biosynthetic pathway have been characterized in mammalian cells, yeasts, and trypanosomes (Ferguson, 1999; Orlean and Menon, 2007) . However, relatively little is known about how the modified proteins are targeted to their proper destinations.
In the early secretory pathway, proteins including GPIanchored proteins (GPI-APs) are transported from the ER in vesicles formed by coat protein complex II (COPII). Most proteins are actively sorted and packaged into these vesicles (Belden and Barlowe, 2001b; Malkus et al., 2002) , although a bulk flow export mechanism also exists. GPI attachment to proteins is indispensable for their exit from the ER, otherwise most proteins are degraded by the proteasome through ERassociated degradation. GPI is an ER export signal in protozoan parasite Trypanosoma brucei (McDowell et al., 1998) . In yeasts, GPI-APs are sorted and transported from the ER via vesicles that are distinct from those containing other proteins such as the general amino acid permease Gap1p and pro-a factors (Muniz et al., 2001) . The p24 family proteins are putative cargo receptors recycling between the ER and the Golgi, and members of this family in yeast are required for efficient packaging of GPI-APs (Muniz et al., 2000; Schimmoller et al., 1995) . In mammalian cells, efficient transport of GPI-APs also requires p24 family members (Takida et al., 2008) . However, it remains unclear how the p24 family members are involved in the transport of GPI-APs, and which components and GPI structures actually determine the exit of GPI-APs from the ER (Kaiser, 2000) .
In addition to the early secretory pathways, GPI-APs have unique properties in other secretory and endocytic pathways. Many GPI-APs are transported to the apical side of the plasma membrane in several types of epithelial cells, and to the axonal regions of neuronal cells (Brown et al., 1989; Lisanti et al., 1989; Paladino et al., 2006) . It has also been reported that several GPI-APs are selectively internalized by a unique pathway involving dynamin-independent, Cdc42-and ARF1-regulated endocytic vesicles (Kumari and Mayor, 2008; Sabharanjak et al., 2002) . The GPI anchor functions as a sorting signal for selective targeting of GPI-APs to this pathway. The sorting of GPI-APs to the secretory and endocytic pathways seems to be correlated with their associations with specialized lipid domains, designated lipid rafts or nanoclusters (Brown and Rose, 1992; Goswami et al., 2008; Simons and Ikonen, 1997) . Although there are no satisfactory definitions of these specialized lipid domains, certain lipids form membrane microdomains that function as platforms for intracellular signaling or are required for selective transport of proteins (Mayor and Riezman, 2004) . GPI is synthesized from phosphatidylinositol (PI) containing an unsaturated fatty acid at the sn-2 position, whereas GPI-APs have a saturated fatty acid at the sn-2 position in mammalian cells ( Figure S1 available online). The lipid moieties of the GPI anchors are remodeled after GPI attachment to proteins, and this remodeling is critical for lipid raft association in mammalian cells as well as in yeasts (Bosson et al., 2006; Fujita et al., 2006a; Maeda et al., 2007) .
Unlike other lipid membrane anchoring, such as acylation and prenylation, GPI bears a complex glycan portion between a protein and its lipid anchor. In contrast to the function of the GPI lipid moiety, the function of the glycan moiety is not well understood. There is a structural difference between the glycan moieties of GPI just before attachment to proteins in the ER and GPI-APs on the cell surface ( Figure S1 ). In the GPI biosynthetic pathway, a side-chain ethanolamine-phosphate (EtNP) can be attached to the second Man (Man2) of the GPI intermediate by PIG-G/GPI7 and PIG-F, thereby generating the complete precursor H8 (Hirose et al., 1992; Shishioh et al., 2005) . However, most GPI-APs on the cell surface do not contain this side-chain EtNP on Man2 of GPI (Ferguson et al., 2008) . Therefore, it has been considered that the GPI structure H7, which lacks a sidechain EtNP on Man2, may be the major precursor for protein attachment, and that H8 is a structural variant of H7 with a similar function.
In the present study, we screened mutants defective in GPI-AP transport and identified a gene required for processing of the glycan moiety on GPI. First, chinese hamster ovary (CHO) mutant cell lines defective in transport of GPI-APs were established. The mutant cells exhibited severe transport delay of GPI-APs from the ER to the Golgi. GPI-APs on the cell surface retained a side-chain EtNP on Man2 of the GPI glycan in the mutant cells, whereas this side chain was mostly removed in wild-type (WT) cells. We identified the gene responsible for the defect of the mutant cells and designated it PGAP5 (post-GPI attachment to proteins 5). PGAP5 was a phosphoesterase directly required for removal of a side-chain EtNP from Man2 of GPI to allow efficient exit of GPI-APs from the ER. Our results suggest that remodeling of the GPI glycan regulates the transport of GPIAPs from the ER to the Golgi. To our knowledge, this is the first report to describe the physiological importance of the glycan portion of GPI anchors.
RESULTS

Establishment and Characterization of Mutant Cell Lines
To establish mutant cells defective in GPI-AP transport, FF8 was used as a parental cell line . In the FF8 cell line, expression of a Flag-tagged temperature-sensitive reporter protein, VSVG ex -Flag-GFP-GPI (VFG-GPI), was induced by adding doxycycline at the nonpermissive temperature of 40 C, thereby causing accumulation in the ER of VFG-GPI, which could then be released from the ER all at once by shifting the temperature to 32 C ( Figure S2 ). Transport of VFG-GPI to the plasma membrane was monitored by flow cytometry of the surface expression of the Flag-tag at various times after the temperature shift. FF8 cells were mutagenized with N-methyl-N'-nitro-N-nitrosoguanidine and several rounds of similar transport assays were performed to sort out the mutant cells displaying delayed transport of VFG-GPI. Mutant clones 9 (C9) and 19 (C19) cells were finally obtained ( Figure 1A ). C9 and C19 mutant cells exhibited defective transport of the reporter protein ( Figures  1B and 1C ; data for C9 not shown). Transport of a transmembrane protein, Flag-VSVG full -GFP (FVG-TM), to the cell surface was barely affected in these mutant cells ( Figures 1D and 1E ), indicating that GPI-AP transport was selectively delayed in these mutant cells. We investigated whether the mutant cells were defective in genes known to be involved in GPI biosynthesis and remodeling. Steady-state surface expression of GPI-APs and GPI biosynthesis were normal ( Figures S3A and S3B ). We also confirmed the normal PI-phospholipase C (PLC) sensitivity of GPI-APs ( Figure S3C ), indicating that the mutant cells were not defective in the GPI-inositol deacylase PGAP1 (Tanaka et al., 2004) . The fatty acid remodeling of GPI-APs, which is essential for the association of GPI-APs with lipid rafts (Maeda et al., 2007) , was also normal as assessed by association of GPI-APs with detergentresistant membranes ( Figure S3D ). These results indicate that the mutant cells do not have a defect in the biosynthesis and lipid remodeling of GPI.
ER-to-Golgi Transport of GPI-APs Is Impaired in Mutant Cells
Next, we analyzed decay-accelerating factor (DAF), a GPI-AP, in the mutant cells to determine whether the mutant cells exhibit defective transport from the ER to the Golgi. Western blotting analysis of steady-state levels of ER and mature forms of DAF showed that in WT cells, the ER form (45 kDa) was smoothly transported to the Golgi where it accepted O-glycans and modification of the N-glycan to become the mature form (70-75 kDa), but that the ER form accumulated in the mutant cells (Figure 2A ). Pulse-chase analyses revealed that transport of DAF from the ER to the Golgi was severely delayed in the mutant cells ( Figures  2B and 2C ), whereas the ER-to-Golgi transport of VSVG was normal ( Figures S4A and S4B) . We further tested GPI-APspecific transport delay in C19 mutant cells using VFG-GPI. Due to the presence of a furin-cleavage site between VSVG and Flag-GFP parts, the reporter protein becomes smaller in size after arrival at the trans-Golgi network. As expected, conversion of the reporter protein from the 85 kDa form to the 30 kDa form was severely delayed in the mutant cells ( Figures  2D and 2E ). Taken together, these results indcate that the mutant cells were selectively impaired in the transport of GPIAPs from the ER to the Golgi.
Expression Cloning of PGAP5, the Gene Responsible for the Defect in GPI-AP Transport The gene responsible for the defective transport in C19 cells was identified by expression cloning based on restored protein transport. A retrovirus cDNA library prepared from human brain was used for the expression cloning. The identified gene, designated PGAP5, was previously recorded as metallophosphoesterase 1 (MPPE1; gene accession number NM_023075 for Homo sapiens), but its function was unknown. Human PGAP5 encodes a membrane protein bearing a phosphoesterase motif on the lumenal side and an ER retrieval signal at the C terminus. Transfection of human and mouse PGAP5 cDNAs restored the delayed transport of GPI-APs in both C9 and C19 mutant cells (Figures 3A and S5A) . Accumulation of the ER form of DAF was also diminished by transfection of human PGAP5 ( Figure S5B ). To confirm that PGAP5 was the primary defect in these mutant cells, we identified the hamster PGAP5 gene, analyzed its cDNA from the C9 and C19 mutant cells, and found that 75 bases between positions 480 and 554 from the start codon were deleted in both mutant cells . The region deleted in the mutant cells corresponds to exon 6 in the human and mouse PGAP5 (NM_023075 for H. sapiens and NM_172630 for Mus musculus), suggesting that the mutant cells have a defect in the exon-intron boundary of exon 6. We analyzed the genomic PGAP5 and revealed a GA transition at the donor splice site of intron 6 (gtgagt to gtgaat), which is known to cause skipping of exon (Tavassoli et al., 1997) , in C19 mutant cells (Figures S7D and S7E) . When the hamster PGAP5 cDNAs were transfected into C19 cells, WT cDNA, but not the mutant cDNA, restored the delayed transport of GPI-APs (data not shown). Therefore, the defect in PGAP5 is the primary cause for the phenotypes of the mutant cells.
PGAP5 Is Localized at the ER-Exit Site, ERGIC, and cis-Golgi
We next examined the cellular localizations of PGAP5 in CHO and normal rat kidney (NRK) cells. HA-tagged PGAP5 (HA- 35 S]methionine/ cysteine followed by chasing for the indicated times. DAF was immunoprecipitated using monoclonal anti-DAF antibody, separated by SDS-PAGE under reducing conditions, and analyzed using a BAS analyzer. The asterisks indicate nonspecific bands. The band intensities of the ER and mature forms of DAF were quantified and plotted as the means ± standard deviation (SD) from three independent experiments (C).
(D and E) Transport analysis of VFG-GPI from the ER to the Golgi. VFG-GPI was expressed in WT and C19 cells at 40 C for 24 hr, followed by incubation at 32 C for the indicated times in the presence of 100 mg/ml cycloheximide, and detected with an anti-GFP antibody. The band intensities of unprocessed and processed VFG-GPI were quantified and plotted as the means ± SD from two independent experiments (E).
hPGAP5), which fully restored the mutant phenotypes ( Figure 3A ), was constructed to investigate the localization. HA-hPGAP5 signals were detected strongly in the perinuclear area and as dot-like structures more dispersedly ( Figure 3B , left panels). Signals of HAhPGAP5 were not colocalized with those of the ER marker calnexin (CNX) (top panels). The signals in the perinuclear area merged with those of the Golgi marker GPP130 (bottom panels), whereas the majority of dotlike signals of HA-hPGAP5 were colocalized with ER-Golgi intermediate compartment (ERGIC)-53 and b-COP (third and fourth sets of panels from top, respectively). Some of the dot-like signals were colocalized with the ER-exit site marker Sec16 (second set of panels from top). ERGIC-53 and b-COP are localized at the ERGIC and cis-Golgi (Klumperman et al., 1998) . To strengthen the point that PGAP5 is in the ERGIC, we incubated cells in 5 mg/ml of brefeldin A to relocalize Golgi, but not ERGIC, proteins to the ER (Lippincott-Schwartz et al., 1990) . Under these conditions, dot-like PGAP5-expressing structures remained, supporting the ERGIC localization of PGAP5 (Figure 3C ). Therefore, HA-hPGAP5 is distributed in the ER-exit site, ERGIC, and cis-Golgi, although it should be noted that HA-hPGAP5 may be expressed higher than endogenous PGAP5 and had wider distribution than that of endogenous PGAP5.
The ER retrieval signal KxKxx at the C terminus is conserved among PGAP5 homologs from fish to primates except for rodents ( Figure S6 ). To check whether the ER retrieval signal is functional, the two Lys residues of the signal were replaced with Ala (K2A). The K2A protein localization at the dot-like structures was diminished ( Figure 3D ), suggesting that the C-terminal KxKxx motif functions as an ER retrieval signal and that PGAP5 recycles between the ER and the Golgi. The ability of K2A PGAP5 in restoring transport in C19 mutant cells was severely diminished as expected ( Figure S8 ). 
PGAP5 Is Associated with GPI-AP and p23
Since the transport of GPI-APs was specifically delayed in the PGAP5 mutant cells, we analyzed whether PGAP5 is associated with GPI-APs. To confirm the association of PGAP5 with GPIAPs, immunoprecipitation of HA-hPGAP5 was performed. As a control, HA-tagged aldehyde dehydrogenase (ALDH) encoding an ER protein was used ( Figure 4A ). We also included H158A, an active site mutant of PGAP5 to see whether the active site is important for association. VFG-GPI was weakly, but specifically, coprecipitated with PGAP5 ( Figure 4A , third panel from top). Surprisingly, PGAP5 was also bound to p23 (fourth panel from top). The p24 family members, including p23, are known to be required for efficient transport of GPI-APs from the ER in both yeasts and mammalian cells (Schimmoller et al., 1995; Takida et al., 2008) . On the contrary, the transmembrane proteins ERGIC-53 and GPP130 were not coprecipitated with PGAP5 (bottom two panels). To examine whether the association of PGAP5 with VFG-GPI depends on the GPI anchor, we performed immunoprecipitation experiments with a construct that was similar but involved the transmembrane protein FVG-TM. The C19 mutant cells shown in Figure 4A were transiently transfected with FVG-TM and an immunoprecipitation analysis was performed similarly. FVG-TM was not coprecipitated with PGAP5 ( Figure S9 ), suggesting that PGAP5 is associated with VFG-GPI via the GPI portion.
Accumulation of GPI-AP in the ER but Not the ER-Exit Site in the Absence of PGAP5 Because PGAP5 partly exists in the ER-exit site ( Figure 3B ) and is associated with GPI-APs ( Figure 4A ) and because a defect in PGAP5 caused delayed ER-to-Golgi transport of GPI-APs (Figure 2) , we next analyzed localization of GPI-APs (EGFP-F-CD59, a fusion protein of EGFP and CD59) in WT, C19, and HA-PGAP5-carrying C19 cells. Whereas WT and HA-PGAP5-carrying C19 cells had strong cell-surface expression of EGFP-F-CD59, C19 cells showed the ER expression of EGFP-F-CD59 in addition to the cell surface ( Figure 4B ). The expression pattern of EGFP-F-CD59 in C19 cells was nicely overlapped with that of the ER marker mRFP-KDEL ( Figure 4C ). The expression pattern of EGFP-F-CD59, however, was not coincided with that of the ER-exit site marker Sec13. The red dots representing mStrawberry-labeled Sec13 (Nagaya et al., 2008) were mainly seen in the areas where the green color of EGFP-F-CD59 was dull ( Figure 4D ). It is, therefore, suggested that GPI-AP is not accumulated in the ER-exit site but rather that GPI-AP is not found clearly in the ER-exit site in the absence of PGAP5. To confirm that GPI-AP is not accumulated in the ER-exit site in C19 cells, we monitored the transport of VFG-GPI after temperature block and release. In WT cells, VFG-GPI that accumulated in the ER at time zero appeared in the Golgi at 10 min and nearly completely moved to the Golgi by 20 min ( Figure S10 ). In C19 cells, the appearance of VFG-GPI in the Golgi was slow and the ER pattern remained even at 30 min. However, a dot-like pattern was not seen during the monitoring period, supporting that it has a defect in the GPI-APs sorting to the ER-exit site for the effective transport when PGAP5 is not functioning.
Structural Analysis of the GPI Anchor
The GPI glycan contains several phosphodiester bonds. Since PGAP5 possesses a phosphoesterase motif, we investigated whether the GPI glycan structure is changed in the mutant cells. His-Flag-GST-Flag-tagged CD59 (HFGF-CD59) was permanently expressed in WT, C19, and HA-PGAP5-carrying C19 cells, isolated from their cell surface and analyzed by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) after trypsin digestion. The molecular ions of the C-terminal peptide bearing GPI were screened by the presence of GPI-specific collision fragments of m/z 422.1+ (glucosaminyl-inositol-phosphate, GlcN-Ino-P) and 447.1+ (ethanolamine-phosphate-mannosyl-glucosamine, EtNP-Man-GlcN) in the second MS. As reported previously (Taguchi et al., 1994; Tashima et al., 2006) , most of the peptides bearing GPI consisted of peptide-EtNP-Man-Man-(EtNP)Man-GlcN-Ino-P in WT cells ( Figure 5A ). In contrast, the majority of the GPI structures in the mutant cells had an additional side-chain EtNP attached to Man2 ( Figure 5B ). In the revertant cells permanently expressing HA-tagged PGAP5, the structures had reverted to those of the WT cells ( Figure 5C ). These results indicate that PGAP5 is required for removal of a side-chain EtNP from Man2.
Enzymatic Activity of PGAP5
To determine whether PGAP5 is the enzyme, we expressed His6-Flag-tagged PGAP5 (HF-PGAP5) in CHO cells, purified it, and established an in vitro enzyme assay. HF-PGAP5 was sequentially purified using a Ni column and anti-Flag beads and analyzed by silver staining. A prominent silver-stained band that migrated with a molecular mass of 50 kDa was confirmed to be HF-PGAP5 by western blot analysis with an antiFlag antibody ( Figure 6A ). Although the natural substrate for PGAP5 was considered to be protein-linked GPI, it seemed difficult to measure its structural change and to prepare it in a sufficient amount. Therefore, we first measured the phosphoesterase activity using several artificial substrates, including p-nitrophenyl phosphate and monofluorophosphate. However, HF-PGAP5 did not recognize these molecules as substrates (data not shown). We subsequently used the GPI intermediate H8 as a substrate. H8 has structure EtNP-Man-(EtNP)Man-(EtNP)Man-GlcN-(acyl)PI, which is a complete precursor just before GPI attachment (Hirose et al., 1992) . When [
14 C]Manlabeled H8 was incubated with HF-PGAP5, it was efficiently converted into H7 lacking the side-chain EtNP on Man2 ( Figure 6B ), indicating that PGAP5 is the enzyme involved in the removal of EtNP from Man2 of GPI. The PGAP5 activity was time dependent and the reaction was linear up to 45 min under the conditions used ( Figures 6C and 6D ). The enzyme exhibited optimal activity at pH 7.0-7.5 ( Figures 6E and 6F Figures 6G and 6H ).
PGAP5 Enzymatic Activity Is Essential for Efficient Transport of GPI-APs
PGAP5 has a phosphoesterase motif ( Figure 7A ), which is conserved among dimetal-containing phosphoesterase proteins, including 5 0 -nucleotidases, sphingomyelinases, and purple acid phosphatases (PAPs). We attempted to build a 3D structural model of the lumenal domain of human PGAP5. Using a fully automated homology modeling system (FAMS) that incorporates query sequence information in combination with structural information (Ogata and Umeyama, 2000) , we successfully identified pig PAP as a remote homolog of human PGAP5. The model of the PGAP5 lumenal domain was then built based on the 3D structure of pig PAP (PDB code: 1UTE) ( Figures 7B and 7C) . The metalcoordinating residues found in the dimetal-containing phosphoesterase family are entirely conserved in PGAP5 homologs from yeast to humans ( Figure S6 ). For human PGAP5, the residues are Asp77, His79, Asp119, Asn157, His158, His249, His303, and His305, whose side chains are structurally equivalent to those of Asp14, His16, Asp52, Asn91, His92, His186, His221, and His223 in pig PAP, respectively. Since PGAP5 was found to be a Mn 2+ -dependent enzyme, the dimetal center was modeled with two Mn 2+ ions. An EtNP was arranged on the putative catalytic site based on the phosphate in the PAP-phosphate complex ( Figures 7D and 7E ). The residues required for the metal binding and phosphoesterase activity were replaced with Ala or Asn. The mutant PGAP5 constructs were stably transfected into the C19 mutant cells, and the GPI-AP transport assay was performed. Transfection of the PGAP5 cDNA with mutation in the putative active site did not restore the delayed transport in the C19 cells, whereas transfection of WT PGAP5 did restore the transport ( Figure 7F ). Taken together, these results suggest that the enzymatic activity of PGAP5 is essential for the efficient transport of GPI-APs. The ratios were calculated from the peak area of each species of parental ion. These structures contain GPI peptides bearing N-acetylhexosamine attached to Man1 as reported previously (Tashima et al., 2006) . . HF-PGAP5 affinity-purified from stably transfected CHO cells was subjected to SDS-PAGE (lane 1: 10 ml sample; lane 2: 20 ml), followed by silver staining. M, molecular size markers; WB, western blotting with an anti-Flag antibody.
(B) PGAP5 removes a side-chain EtNP from Man2. Purified HF-PGAP5 or buffer was incubated with [ 14 C]Man-labeled H8, which consists of (EtNP)Man-(EtNP)Man-(EtNP)Man-GlcN-(acyl)PI, in a buffer comprising 50 mM MES/HEPES (pH 6.5), 100 mM NaCl, 0.1 mM MnCl 2 , 0.1 mM MgCl 2 , 0.1 mM CaCl 2 , and 0.1% Triton X-100. After a 12 hr incubation at 37 C, the lipids were analyzed by TLC using a solvent system of chloroform/methanol/water (10:10:3). ERGIC-53, a lectin-type cargo receptor, recognizes properly processed N-linked glycans and promotes enrichment of several glycoproteins in transport vesicles (Appenzeller et al., 1999; Hauri et al., 2000) . Although sorting mechanisms for GPI-APs to the ER-exit site is poorly defined, it is postulated that the GPI moiety is recognized by cargo receptors and acts as a signal for sorting of GPI-APs (Mayor and Riezman, 2004) . In the present study, we established mutant cells that were selectively defective in transport of GPI-APs from the ER and identified the gene PGAP5 as being responsible for the defect. Strikingly, PGAP5 is an enzyme that removes the side-chain EtNP on Man2 from GPI anchors, suggesting that the processing of the GPI glycan mediated by PGAP5 is critical for efficient GPI-AP transport from the ER to the Golgi ( Figure 7G ). These findings demonstrate that the GPI glycan functions as an ER-exit signal and regulates GPI-AP transport in the early secretory pathway. It is most likely that EtNP cleavage by PGAP5 occurs in the ER rather than in the ERGIC or the Golgi because the defect in PGAP5 results in the accumulation of GPI-APs in the ER and their transport delay from the ER, and the PGAP5 enzymatic activity was optimal at pH 7.0-7.5, which is consistent with the pH in the ER. Furthermore, PGAP5 was partially localized at the ERexit site, although a significant fraction of PGAP5 was also found in the ERGIC and the Golgi. We suggest that PGAP5 is recycled between the ER and the Golgi, but it remains to be determined whether transport of PGAP5 to the Golgi is required for its function or not and how PGAP5 is transported from the ER. Enzymatic activity of PGAP5 was found to be critical for cargo sorting given that the active site-dead PGAP5 mutant could not restore the delayed transport of GPI-APs in the C19 mutant cells. Therefore, it seems that the side-chain EtNP behaves like a molecular signature for entry of GPI-APs into the ER-exit site and subsequent cleavage of the EtNP is essential for the transport ( Figure 7G ). PGAP5 may recruit or trap GPI-APs and concentrate them at the ER-exit site.
Interestingly, PGAP5 was associated with p23, a p24 family protein. Members of the p24 family have been reported as putative cargo receptors for GPI-APs in yeasts (Muniz et al., 2000) . The p24 proteins play key roles in maintaining the fidelity of GPI-AP vesicle transport from the ER, but these are unlikely to be the only functions of p24 complexes (Kaiser, 2000) . emp24 and erv25 mutants showed defective transport of invertase, a soluble secreted protein (Schimmoller et al., 1995) . Mutations of several yeast p24 genes resulted in secretion of BiP/Kar2p (Belden and Barlowe, 2001a) . These results suggest that p24 proteins may act as cargo receptors together with specific partners that recognize the cargos. We speculate that PGAP5 recruits and sorts GPI-APs together with p24 heteromeric complexes to the ER-exit site. Another possibility is that p23 interaction with PGAP5 may occur during recycling of PGAP5 between the ER and the Golgi because p23 is also involved in retrograde transport of vesicles from the Golgi to the ER. These possibilities will be addressed in further studies.
Several previous studies in yeasts support our idea that PGAP5 is involved in recruitment and sorting of GPI-APs. The yeast genome contains two PGAP5 homologs, CDC1 and TED1. TED1 is thought to act together with EMP24 and ERV25 in the ER exit (Haass et al., 2007) . TED1 was found during screening for genes necessary for cell-surface expression of a potassium channel, Kir. In this screening, BST1, EMP24, and ERV25 were also isolated. BST1 encodes a yeast homolog of PGAP1, which is GPI inositol deacylase (Fujita et al., 2006b; Tanaka et al., 2004) . From the genetic analysis, it is predicted that Bst1p and Ted1p function in the Emp24p/Erv25p-dependent trafficking pathways (Haass et al., 2007) . Furthermore, ted1 mutant cells show delayed transport of a GPI-AP, Gas1p, from the ER, suggesting that GPI-APs processed by Ted1p/PGAP5 become associated with p24 family-dependent pathways. Unless the second EtNP on GPI is removed by PGAP5, GPI-APs may not become concentrated into p24-dependent vesicles.
The other yeast homolog, CDC1, was originally identified in a screen for cell division cycle defects (Hartwell et al., 1970) and encodes an ER-localized protein implicated in actin polarization and the inheritance of late Golgi elements (Losev et al., 2008; Rossanese et al., 2001) , although its biochemical functions remain unknown. cdc1 mutant cells are rescued by addition of Mn 2+ , consistent with the requirement of Mn 2+ for PGAP5 enzymatic activity. The temperature sensitivity of cdc1 mutant cells is suppressed by additional mutations in COS16/PER1 (Paidhungat and Garrett, 1998) and GUP1 (Losev et al., 2008) . Both Per1p and Gup1p are involved in lipid remodeling of GPI-APs in yeast (Bosson et al., 2006; Fujita et al., 2006a) . Since the additional mutations in PER1 or GUP1 suppress the phenotypes in cdc1 mutant cells, Per1p and Gup1p function at the epistatic position of Cdc1p. In yeasts, lipid remodeling of GPI-APs is carried out before their exit from the ER (Fujita and Jigami, 2008) , further supporting that Cdc1p/PGAP5 acts at the final step for sorting of GPI-APs to the ER-exit site. It is not clear why two PGAP5 homologs exist in yeast. In yeast, however, two types of lipid remodeling of GPI-APs take place in the ER, resulting in GPI-APs containing either ceramide-based lipid or diacylglycerol-based lipid containing very long fatty acid at the sn-2 position (Sipos et al., 1997) . One possibility is that two PGAP5 homologs are required for the recognition and cleavage of the side-chain EtNP from yeast GPI-APs containing different lipid moieties. In the GPI biosynthetic pathway, EtNP is transferred to Man2 of GPI intermediate H7 by an ethanolamine-phosphotransferase PIG-G/GPI7 and PIG-F to generate H8, but the physiological function had not been understood. H7 was thought to be the major substrate for protein anchoring because the GPI structures of GPI-APs on the cell surface mostly lack the second side-chain EtNP, despite the existence of H8 as a GPI precursor. In the present study, we found that more than 80% of HFGF-CD59 retained the side-chain EtNP on Man2 in the C19 mutant cells, indicating that H8 is the major substrate for attachment to proteins. The side-chain EtNP on Man2 is then eliminated by PGAP5 after attachment to proteins, which is crucial for the efficient transport of GPI-APs from the ER. Therefore, the side-chain EtNP is a transient modification of Man2 present only in the final GPI precursor and the nascent GPI-APs and may act as a signal to concentrate GPI-APs to the ER-exit site ( Figure 7G ). It is very likely that ER-to-Golgi transport of GPI-APs is delayed like in PGAP5-defective cells, when the side-chain EtNP on Man2 is not attached due to defective PIG-G/GPI7. In gpi7-defective yeast, ER-to-Golgi transport of GPI-APs is in fact delayed (Benachour et al., 1999) . It is, however, unclear whether this is a direct effect of a lack of the side-chain attachment or if GPI-AP transport is indirectly affected by a defective lipid remodeling to ceramide-type GPI known to be caused by GPI7 deficiency.
Homologs of PGAP5 are found in the genome database of a wide variety of organisms, suggesting that attachment by PIG-F/GPI7 and detachment by PGAP5 of the side-chain EtNP on Man2 is widely used in various organisms for efficient transport of GPI-APs. However, there is no PGAP5 homolog in trypanosomes that abundantly generates GPI-APs. Consistent with this, T. brucei does not appear to have a GPI7 homolog, indicating that efficient transport of GPI-APs is achieved in trypanosomes by means of other mechanisms.
There is a report that free GPI including H8 is found in the plasma membrane, indicating that free H8 can be transported from the ER to the plasma membrane (Baumann et al., 2000) . If a similar mechanism applies to ER export of free GPI, transport of H8 must be slower than that of H7. However, transport of free GPI might be mediated by a route different from that of GPI-APs.
Although we have clarified one important role of the GPI glycan in the transport of GPI-APs at the cellular level, whether such a GPI glycan-dependent regulation of a secretory pathway has an impact on the physiology of animals remains unknown. These questions should be addressable now that PGAP5 and its functions have been identified.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Data.
Establishment of C9 and C19 Mutant Cells and Expression Cloning of PGAP5 FF8 cells were treated with 1 mg/ml N-methyl-N'-nitro-N-nitrosoguanidine for 20 hr and cultured for 1 week. Subsequently, cells with delayed surface expression of the reporter protein were enriched by several rounds of cell sorting using a FACSAria (BD Bioscience). The population obtained by this sorting procedure was subjected to limiting dilution, and two clones were selected and designated the M85-C9 and M85-C19 cell lines (referred to as C9 and C19 cells, respectively).
To use a retrovirus system for expression cloning of the responsible gene, C19 cells transiently expressing mouse CAT1, a receptor for ecotropic retroviruses, were created by transfection of pME-mCAT1. The cells were then infected with a human brain retroviral cDNA library (Clontech). After transport assays, the cells were stained for Flag epitope, and cells expressing high levels of the reporter protein were enriched 3-fold by the FACSAria. Several cell lines that exhibited normal transport of the reporter protein were obtained by limiting dilution from the enriched cell pool. Genomic DNAs were extracted from each cell line, and retrovirus-derived cDNAs integrated into the genome were amplified by PCR.
Transport Assay of Reporter Proteins
Cells derived from FF8 cells were cultured in complete medium containing 1 mg/ml doxycycline at 40 C for 24 hr, quickly harvested with trypsin-EDTA solution (Sigma), and incubated in complete medium at 32 C for the required times. The cells were stained with an M2 anti-Flag antibody and PE-conjugated goat anti-mouse IgG and analyzed using a FACSCalibur (BD Biosciences) or the FACSAria. In some cases, cells were transiently transfected with expression plasmids for reporter proteins using Lipofectamine 2000. At 10-12 hr after transfection, the temperature was shifted to 40 C and the cells were cultured for a further 24 hr, followed by incubation at 32 C for the required times. In addition to the first gating (FSC and SSC), a second gating to select cells expressing the same amount of reporter protein (brightness of EGFP in FL1) was performed for analysis using the CellQuest Pro software (BD Bioscience).
In Vitro Assay for PGAP5 Enzymatic Activity [ 14 C]H8 was dried and resuspended by vortexing and sonication in reaction buffer comprising 50 mM MES/HEPES (pH 5-8), 100 mM NaCl, 0.1% Triton X-100, 0.1 mM MnCl 2 , 0.1 mM MgCl 2 , 0.1 mM ZnCl 2 , and 0.1 mM CaCl 2 . For measurements of pH or metal dependency, the compositions of the reaction buffer were changed properly. The reactions were started by addition of purified HF-PGAP5, followed by incubation at 37 C for 30 min. The reactions were stopped with addition of water-saturated 1-butanol and kept on ice. After butanol partitioning and drying, the samples were analyzed by TLC with a solvent system of chloroform/methanol/water (10:10:3).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and ten figures and can be found with this article online at http://www.cell.com/ supplemental/S0092-8674(09)01114-3.
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